DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Hyoscyamine is an investigational drug.
There have been 3 clinical trials for Hyoscyamine. The most recent clinical trial was a Phase 1 trial, which was initiated on November 12th 2018.
The most common disease conditions in clinical trials are Abdominal Pain, Urinary Bladder Neoplasms, and Lower Urinary Tract Symptoms. The leading clinical trial sponsors are National Cancer Institute (NCI), FKD Therapies Oy of Finland, and University of Kansas Medical Center.
Recent Clinical Trials for Hyoscyamine
|Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation||University of Kansas Medical Center||Phase 4|
|Efficacy of Open Label Placebo in Children With FGIDs||Nationwide Children's Hospital||N/A|
|Efficacy of Open Label Placebo in Children With FGIDs||Boston Children’s Hospital||N/A|